CDC Viral Hepatitis Professional Tools
CDC’s compilation of resources for diagnosing and managing hepatitis A, B, and C.
Topic: Clinical Tools and Guidelines
Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice
July 23, 2020
The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.
The following topics are covered in detail:
- The rationale used in developing the Guidelines
- How various abnormalities should be managed
- Interactive demonstrations of how to use the app
- Specific considerations for the application of Family PACT benefits, including coding and billing
Learning objectives: At the end of this session, the learner will be able to:
- Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
- Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
- Demonstrate use of the ASCCP app to apply the new guidelines to patient care.
Presenters:
Resources
STD Expert Hour Webinar – Genital Dermatology 101
June 1, 2020
Dr. Kenneth Katz covers the following learning objectives for this webinar:
- Differentiate between genital skin diseases
- Formulate differential diagnoses for genital skin disease
- Identify genital skin diseases that warrant referral to specialty care
National Coalition for Sexual Health Tools for Healthcare Providers
This guide can help healthcare providers better integrate sexual health conversations and recommended preventive services into routine visits with adolescents and adults.
Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment
June 20, 2019
Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.
This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.
Learning objectives:
- Understand current guidelines for screening for CT and GC among sexually active women and men
- List the indications for anorectal and oropharyngeal CT/GC screening
- Explain when test-of-cure is indicated
- Identify the proper ICD-10 codes for lab requests and billing information
Presenters:
Resources:
Extragenital Screening
Don’t forget to swab! Among men who have sex with men, 84% of gonorrhea and chlamydia infections would be missed with urine-only screening1. Make sure your clients are screened for gonorrhea and chlamydia of the throat and rectum.
| What: | Extragenital Screening for Gonorrhea and Chlamydia |
| Where: | Rectum and throat |
| Who: | Men who have sex with men (MSM), transgender women, people living with HIV, and people on PrEP who report having receptive anal and/or oral sex |
| When: | At least annually, or every 3 to 6 months as needed based on exposure |
| Why: | When urine-only screening is performed, up to 90% of rectal gonorrhea and 77% of rectal chlamydia infections remain untreated1. HIV-negative men diagnosed with rectal infections are excellent candidates for PrEP, because they have a high risk of HIV infection |
| How: | Swab specimen (self or clinician-collected swab) |
The California Prevention Training Center supports clinics and providers in implementing rectal and pharyngeal STI screening.
For more information, contact us.
Resources for Providers
Extragenital Chlamydia and Gonorrhea Among Community Venue–Attending MSM, CDC MMWR
April 11, 2019
CA Department of Public Health, Dear Colleague Letter
February 20, 2019
National Coalition of STD Directors – Extragenital Testing
NYC Department of Health and Mental Hygiene – STI’s Among MSM Protocol Card
Resources for Clinics
Self Swab Instructional Posters:
CDC Recommendations for Laboratory-Based Detection of Gonorrhea and Chlamydia, March 14, 2014
Verification of Patient Self-Collected Extragenital Nucleic Acid Amplification Tests
- Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sexually transmitted diseases. 2011 Oct 1;38(10):922-4.
Congenital Syphilis Algorithm
This algorithm provides recommendations for the evaluation and management of infants <30 days old with in-utero exposure to syphilis
Extragenital Screening Resources
Extragenital (rectum and throat) gonorrhea and chlamydia screening resources for providers, clinics, and patients.
Taking A Sexual History – Using the 5Ps (A Practical Guide for Clinicians)
Dr. Christoper Ried, Medical Director of HIV/STD Services for Orange County, demonstrates a sexual health history screening using the 5Ps of taking a sexual history.
Secondary Syphilis Patient Evaluation Algorithm
Algorithm to evaluate patients for secondary syphilis. Includes sexual history taking and physical exam, diagnostic work-up, treatment and follow-up, and reporting and partner management.
